Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5210_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
38 Мб
Скачать
 
320
19.2.2.3  Management
Depending on the state of the tooth, deep scaling, periodontal surgery or extraction of the tooth are suggested.
19.2.3  Necrotising Ulcerative Gingivitis (NUG) and Necrotising Ulcerative Periodontitis
Necrotising ulcerative gingivitis is also known as acute necrotising ulcerative gingivitis (ANUG) and trench mouth. When NUG progresses, it involves periodontal tissues resulting in attach­ment loss. This disease is an acute, rapidly destructive, microbial disease of the gingiva and/or periodontium in immunocompromised and malnourished individuals. It is also an opportun­istic infection associated with organisms such as Bacteroides and Fusobacterium groups (9,24, 25).
19.2.3.1  Clinical Features
These patients present with pain, halitosis, bleeding and ulceration resulting in punched- out interdental papillae. This is characteristic of acute onset. These patients may also have fever, malaise and lymphadenopathy. The diagnosis is mainly based on the clinical presentation (Figure19.8).
19.2.3.2  Management
Treatment is given in two phases. Initially, ultrasonic superficial debridement is followed by anti­biotics such as metronidazole with 0.12% chlorhexidine gluconate mouth rinse. This regimen is followed by scaling, root planing and maintaining good oral hygiene. If NUG is not controlled at this stage, it will progress to necrotising ulcerative periodontitis (NUP).
19.2.4  Syphilis, Tuberculosis andGonorrhea
Bacterial oral infections caused by Treponema pallidum, Mycobacterium tuberculosis and Neisseria gonorrhoeae are varied and uncommon. Early and effective management is essential. Bacterial
infections are infrequent due to the protective role of the oral epithelium and the antibacterial properties of saliva. Bacterial infections are more frequent in immunocompromised patients such
Figure19.8  Clinical photograph
showing punched- out interdental papillae.
t.me/Dr_Mouayyad_AlbtousH
       
as those receiving chemotherapy, organ transplantation, human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) and corticosteroid use.
19.2.4.1  Syphilis
Syphilis is a sexually transmitted disease caused by Treponema pallidum, a spirochete transmitted through direct contact with oral, genital or anal mucosae. Other routes of infection include blood transfusion (rarely) and intrauterine maternal/fetal transmission(26, 27).
19.2.4.2  Aetiology andPathogenesis
Syphilis is caused by the spirochete, Treponema pallidum. The Treponema genus is a spiral- shaped bacteria with a rich outer phospholipid membrane that belongs to the spirochetal order. The clinical manifestations of the disease, particularly in the secondary and tertiary stages, are so variable that the term ‘The great imitator’ has been applied. Syphilis is considered a sexually transmitted disease, except for transplacental transmission from an infected mother. The ‘primary’ lesion occurs at the site of inoculation on the genitals, anus, rectum, lips and mouth. This lesion, known as a ‘chancre’, appears 10– 90days following exposure with an average of 20 days. Even without treatment, the chancre will heal. About 25% of individuals will then develop ‘secondary’ syphilis with a wide vari­ety of clinical signs and symptoms. Again, even without treatment, the lesions will clear, although the period for resolution is highly variable. Some individuals will then enter a long ‘latent’ period 10– 30 years later when the manifestations of ‘tertiary’ syphilis develop. Tertiary syphilis, most com­monly involving the cardiovascular and nervous stems, is rare today, at least in developed countries because of the widespread use of antibiotics, both in treating syphilis and given for other infections.
The mechanism of tissue injury by T. pallidum and effective immune response is not well understood. Experimental studies in rabbits suggest that much of the tissue injury is due to the ineffective reaction of the immune system, rather than the organism itself, producing chronic inflammation and ischemic necrosis secondary to obliterative endarteritis. Although the pri­mary and secondary lesions appear to be cleared by an immune response, chronic infection results in delayed hypersensitivity reaction and granulomatous response, leading to the forma­tion of ‘gummas’. Systemic elimination of T. pallidum does not occur, leading to a period of ‘Latency’. When immune surveillance becomes ineffective, the manifestations of ‘tertiary’ syphilis may develop.
Syphilis is a much more aggressive disease when associated with AIDS. In this circumstance, primary and secondary syphilis may occur simultaneously as well as multiple chancres. Progression to tertiary syphilis is rapid, especially with neurologic involvement. Treatment requires higher doses of penicillin, and relapse may occur following treatment(28– 31).
321
19.2.4.3  Clinical Features
Signs and symptoms of syphilis are multiple and depend on the stage of the disease. Primary syphilis is characterised by a painless ulcer, known as a chancre, at the site of contact. This non­painful ulceration appears on the lips and occasionally elsewhere in the oral cavity, lasting three to eight weeks. Secondary syphilis, following the primary infection, usually manifests with sys­temic symptoms and multiple oral lesions. These painless lesions can occur anywhere in the oral cavity as patches, split papules and condylomata lata. After this stage, the patients manifest no symptoms entering into latent syphilis lasting for weeks to years. Tertiary syphilis follows the latent phase, affecting multiple organs. Gummas are the active sites of tertiary infection in the pal­ate leading to perforation and are histologically characterised by granulomatous inflammation.
t.me/Dr_Mouayyad_AlbtousH
 
322
19.2.4.4  Management
A definitive diagnosis of syphilis generally requires at least one positive nontreponemal assay (Venereal Disease Research Laboratory [VDRL] and Rapid Plasma Reagin [RPR]) and a positive treponemal test (Fluorescent Treponemal Antibody Absorption Test [FTA- ABS] and Treponema pallidum particle agglutination assay [TP- PA]). Primary and secondary syphilis are treated with a single dose of intramuscular long- acting benzathine penicillin G, while tertiary syphilis is treated with intramuscular benzathine penicillin G once weekly for three to four weeks. Patients allergic to penicillin are treated with tetracycline, doxycycline or ceftriaxone(26).
19.2.4.5  Tuberculosis
Tuberculosis is a granulomatous disease caused by the aerobic acid- fast bacillus, Mycobacterium tuberculosis. Oral tuberculosis may follow primary lung infections in immunosuppressed
patients.
19.2.4.6  Aetiology andPathogenesis
Tuberculosis is caused by Mycobacterium tuberculosis, an ‘acid- fast’ organism, so named because it resists discolouration when stained with the dye carbolfuchsin due to the lipid- rich membrane of the bacteria. This same membrane also renders the organism relatively resistant to disinfectants and antibiotics. Infection is transmitted via person- to- person through infected sputum, often produced by coughing. Following aspiration of infected droplets, the organisms lodge in the pulmonary alveoli, where their presence elicits an innate immune response domi­nated by macrophages. The bacteria may be destroyed if the inoculum is small and the indi­vidual’s immune system is competent. M. tuberculosis, because of its lipid- rich membrane, tends to resist degradation in the phagolysosome of the macrophage and may replicate within the macrophage and be released into surrounding tissue. The adaptive immune response also plays a role in destroying organisms via sensitised T cells. If, however, M. tuberculosis is not killed during the initial immune responses, a granulomatous inflammatory reaction, domi­nated by activated macrophages, results in an attempt to wall off the offending organisms, thus forming a ‘tuberculous granuloma’ with a soft, necrotic centre. The microorganisms may per­sist for years within this granuloma, only becoming proliferative when the immune system weakens, AIDS being the best example. These granulomas may expand and rupture into bron­chi, thus producing highly infective sputum.
19.2.4.7  Clinical Features
Oral tuberculosis is rare. Oral tuberculous lesions almost always arise from mycobacteria colonis­ing small areas of oral mucosal disruption, secondarily infected by contaminated sputum(32– 34), although primary oral lesions have rarely been reported. It presents ulcerations usually on the posterior dorsum of the tongue, though it can occur anywhere on the oral mucosa. These persis­tent ulcers are painful and may be associated with enlarged painful cervical lymph nodes. The infected patients may present with fever, night sweats, chronic cough and haemoptysis. A biopsy of the ulcer will reveal a necrotising granulomatous inflammatory reaction unless the individual is immunosuppressed. A positive culture of the organisms is confirmatory(26).
19.2.4.8  Treatment
The patients should be referred to an infectious disease clinic for treatment with a combination of isoniazid, rifampin, pyrazinamide and ethambutol. The treatment should be continued until the sputum is negative for the organisms.
t.me/Dr_Mouayyad_AlbtousH
       
19.2.4.9  Gonorrhea
Gonorrhea, a sexually transmitted disease, is caused by a gram- negative coccobacterium, Neisseria gonorrhoeae. Primary lesions usually involve the reproductive organs but may occur in the oral
cavity, oropharyngeal mucosa and rectum.
19.2.4.10  Aetiology andPathogenesis
Neisseria gonorrhoeae, a highly infectious, gram- negative obligate diplococcus is the cause of gonor­rhoea. The bacteria are mainly transmitted through genital, orogenital and anogenital sexual con­tact, although genito- ocular transmission (gonococcal conjunctivitis) during childbirth is possible.
The bacteria preferentially infect mucosal epithelia of the male and female urethra, endome­trium, fallopian tubes, epididymis, anorectal mucosa, nasopharynx and conjunctiva. As untreated infection progresses, adjacent structures and even distant sites, such as joints, may be involved.
Infected tissue injury appears to occur primarily as a consequence of the immune response with an outpouring of neutrophils resulting in cellular destruction, pus and sometimes abscess forma­tion which may eventuate in scar tissue formation, especially in the fallopian tubes. Although there is a robust innate immune response, the adaptive immune response is less so. Although there may be some suppression of the bacteria, immunity develops only rarely, if at all. Therefore, repeated infections are frequent.
The bacteria attach to and gain entrance to the epithelial cells primarily through the expression of Type IV pili and opacity protein (OPA) interaction. The ability to attach to spermatozoa is a criti­cal feature facilitating infection due to the high bacterial load contained in the ejaculate.
The role of nasopharyngeal infection has become an area of increasing interest because of the development of nucleic acid testing, which is more sensitive than culture in documenting an infected individual. Since nasopharyngeal testing is currently infrequent, it is proposed that many asymptomatic infections go untreated and yet are a source of transmission through orogenital sex. It has been reported that oropharyngeal gonorrhoea is more treatment- resistant than genital infec­tion. Due to increasing antibiotic resistance, only one class of antibiotics, cephalosporins, is now recommended for treatment(35– 41).
323
19.2.4.11  Clinical Features
Males are more frequently affected. Oropharyngeal lesions are usually asymptomatic but can result in a persistently sore throat with ulcerations and flu- like symptoms. Nuclei acid amplifica­tion will assist in confirming infection(27, 28).
19.2.4.12  Management
Centres for Disease Control and Prevention (CDC) recommends a single dose of 500 mg of intra­muscular ceftriaxone.
19.2.5  Oral andMaxillofacial Viral Infections
Oral viral infections include herpes simplex, herpes zoster and the coxsackie group of viruses. Primary herpes simplex and coxsackie viral lesions affect children, while herpes zoster infection affects older patients.
19.2.5.1  Herpes Virus Infections
The Herpes viruses are DNA viruses with eight subtypes causing oral cavity lesions. These include Herpes simplex virus 1 and 2 (HSV- 1 and HSV- 2), Varicella- zoster virus (VZV), cytomegalovirus (CMV), human herpes virus- 8 (HHV- 8 or Kaposi sarcoma- associated herpesvirus) and Epstein– Barr
t.me/Dr_Mouayyad_AlbtousH
 
324
virus (HHV- 4). HSV and VZV cause disease in the young, while CMV causes oral ulcerations. HHV- 8 causes Kaposi sarcoma in the immunocompromised. Epstein– Barr virus causes hairy leu- koplakia in immunocompromised(42– 44).
19.2.6  Pathogenesis of HSV and VZV Infections
19.2.6.1  Herpes Viruses
The three alpha herpes viruses, HSV- 1, HSV- 2 and VZV, share some common features, both pathogenetically and clinically, but differ in other aspects. All three are neurotropic viruses, establishing latent residency usually in the neuronal nuclei of the dorsal root ganglia, although other ganglia may also be infected. HSV- 1/HSV- 2 are transmitted through infected saliva, active oral lesions and genital/orogenital sex. Although HSV- 1 has traditionally been associated with orolabial infection and HSV- 2with genital infection, more recent studies have demonstrated that crossover between sites is not that unusual, especially HSV- 1- producing genital lesions. Following HSV infection of skin/mucosal epithelial cells leading to a symptomatic vesicular rash with grouped blisters, the virus migrates along the sensory nerve fibres to establish latency in neuronal nuclei. The cellular and humoral immune systems will control epithelial infection but will not eliminate the latent infection. Although the mechanism for HSV latency is complex, one crucial factor is the cellular internalisation of CD1d (a human gene), which is usually expressed on the surface of the antigen- presenting cells. This lack of external expression inhibits an immune T- cell response. The latent virus also downregulates viral gene expression. Since neurons do not divide, active viral transcription is minimised.
VZV infection is transmitted through infected respiratory tract secretions or direct/indirect contact with vesicular skin lesions. The initial infection, varicella, is better known as ‘chicken­pox’. After establishing epithelial infection, the virus migrates preferentially to the trigeminal and lumbosacral ganglia, although other sites may also be involved where it enters a latent state. The mechanisms maintaining latency are not well understood, although the cellular immune response is essential in keeping the virus in check. Under various cellular/physiologi­cal stress conditions, VZV undergoes replication and migrates along 1– 3 dermatome regions to produce a symptomatic, vesicular rash, which may be associated with nerve pain. Disseminated infection may be seen with immunosuppression. The development of the VZV vaccine in 1995 dramatically changed the course of the initial infection in children, significantly reducing morbidity/mortality. To what extent the latent state exists after vaccination or to what extent it might be expressed is unclear, although the incidence of shingles in children is significantly reduced if vaccinated(45– 51).
19.2.6.2  Herpes Simplex Infections
HSV- 1 occurs in children, usually as a subclinical infection. Only 1% of the children manifest clini­cal symptoms resulting in primary herpetic gingivostomatitis. The most common form of trans­mission is direct contact with oral secretions. Research has shown that viral shedding may occur without clinical lesions.
19.2.6.3  Clinical Features of HSV
Children present with fever, malaise and cervical lymphadenopathy of two to three days duration. Oral lesions appear as painful ulcerations and vesicles with gingivostomatitis (Figure 19.9). Associated bleeding of the gingiva may be noted.
t.me/Dr_Mouayyad_AlbtousH
       
Figure19.9  Primary herpetic
gingivostomatitis presenting as erythema and pain in the gingiva.
19.2.6.4  Management of Primary HSV
The diagnosis is usually based on clinical appearance. Treatment of fever is managed with antipyretics such as acetaminophen. Aspirin is avoided in children. The lesions heal entirely in about 10days in patients with normal immune status. Immunosuppressed individuals may be treated with antivirals such as acyclovir or valacyclovir.
325
19.2.6.5  Secondary Herpetic Stomatitis andHerpes Labialis
Recurrence in the form of secondary herpetic stomatitis/herpes labialis is due to the reactivation of the dormant virus in the trigeminal ganglion. The predisposing factors include changes in ambient temperature, immunosuppression, uncontrolled diabetes, stress and following dental treatment(45– 51).
19.2.6.6  Clinical Features
Oral lesions occur on the keratinised mucosa of the lips, gingivae and hard palate, initially as grouped vesicles with prodromal symptoms of tingling and pain. The blisters will rupture resulting in grouped ulcerations (Figure19.10). Herpes labialis shows similar vesicles on the lips (Figure19.11
Figure19.10  Secondary herpes
presenting as grouped ulceration on the palate.
t.me/Dr_Mouayyad_AlbtousH
 
326
Figure19.11  Herpes labialis
presenting as grouped vesicles on the left lip.
Figure19.12  Herpes labialis
presenting as a bulla and swelling on the left lip.
and Figure 19.12). When the vesicles and ulcerations are weeping, they are highly infectious. Reactivation lesions occur at the same sites in the oral cavity. The diagnosis is established based on clinical features.
19.2.6.7  Management
Most patients usually need no treatment, but if they are immunosuppressed, they require systemic acyclovir therapy. Topical antiviral therapy, such as penciclovir or acyclovir, used during the prodromal period, may be helpful. It is important to note that treatment with acyclovir, either for primary or secondary herpetic lesions, should be initiated within three days of the onset of symptoms.
19.2.7  Herpes Zoster (Varicella Zoster) Infections
Chickenpox is the primary infection caused by the VZV occurring in children as a rule. The patients may present with systemic signs of infection, fever, malaise and lymphadenopathy. The cutaneous lesions are vesiculopapular with pruritus. Oral lesions can occur on the palate and tonsillar pillar.
19.2.7.1  Varicella Zoster (Shingles)
Varicella Zoster, or shingles, occurs mainly in older patients with a history of chicken pox, present­ing with lesions on the facial, thoracic or lumbar dermatomes. The oral findings seen in shingles are, characteristically, painful vesicles and bullae rupturing over time, causing ulceration (Figure19.13). The prodromal features in the oral cavity resemble odontalgia. The unilateral distribution of vesicles, bullae and ulcerations helps diagnose shingles(45– 47).
t.me/Dr_Mouayyad_AlbtousH
       
Figure19.13  Shingles presenting as
unilateral painful ulceration on the palate.
19.2.7.2  Management
Most healthy patients require only supportive care, while the immunosuppressed may need acyclovir. Post- herpetic neuralgia and Ramsay- Hunt syndrome are complications of oral shingles.
19.2.7.3  Coxsackie Group ofVirus Infections
Coxsackieviruses are divided into A and B. Group A coxsackieviruses tend to infect the skin and mucous membranes. Oral infections include herpangina and hand, foot and mouth disease (HFMD). Both groups can cause non- specific febrile illnesses, rashes, upper respiratory tract infec­tions and aseptic meningitis.
327
19.2.7.4  Herpangina
Herpangina is an enterovirus infection that infects the gastrointestinal tract. Herpangina clinically manifests as an acute febrile illness with small ulcerative or vesicular lesions in the posterior orophar­ynx. Infection is highly infectious. Herpangina is seen mainly in children up to 10 years of age but may affect all ages, from infants to young adults. Herpangina is a self- limiting infection.
19.2.7.5  Aetiology andPathogenesis
The implicated etiological agents of herpangina include coxsackie A16 virus, coxsackie B virus and enterovirus 71 virus serotypes. Infection typically spreads via the faecal– oral route or respiratory droplets(52).
19.2.7.6  Clinical Features
Symptoms include sudden fever, sore throat, headache, loss of appetite and often neck pain. Within two to four days, greyish lumps of 1– 2 mm in diameter form and develop into vesicles surrounded by redness. Over the next 24 hours, these become shallow ulcers of 3– 5 mm in diameter and heal in one to seven days. These lesions most often appear on the tonsillar pillars and the soft palate, tonsils, uvula (Figure19.14) or tongue(52).
19.2.7.7  Management
A diagnosis is made from clinical signs and symptoms. Treatment is usually supportive. The dis­ease is self- limiting and usually runs its course in less than a week.
t.me/Dr_Mouayyad_AlbtousH
 
328
Figure19.14  Herpangina. Shallow
ulcers on the soft palate in a patient with herpangina.  Sterenau/ Wikimedia Commons/CC BY- SA 4.0.
19.2.7.8  Hand, Foot andMouth Disease
HFMD is a common viral childhood disease. HFMD is a common infection caused by a group of enteroviruses(53).
19.2.7.9  Aetiology andPathogenesis
Coxsackievirus A 16 and Enterovirus 71 are the most common etiological agents. HFMD is highly contagious. Nasopharyngeal secretions, including saliva and nasal mucus, transmit infection.
19.2.7.10  Clinical Features
The illness usually begins with one or all of the following: fever, sore throat, loss of appetite and lethargy. However, many children remain well in themselves despite the rash. Blisters on the tops of the hands, feet and/or palms, and soles (Figure19.15a) usually appear one to two days following the fever. Small painful vesicles and ulcers may develop in and/or around the lips and mouth (Figure19.15b) and the throat. The incubation period is typically 3– 6days, and children remain infectious until the blisters have ruptured and healed (usually 7– 10days).
19.2.7.11  Management
HFMD is usually diagnosed clinically. Lesions on the hands, feet and mouth are distributed symmetrically. Specific treatment is not usually required for HFMD; the focus should be sympto­matic care.
t.me/Dr_Mouayyad_AlbtousH
       
(a) (b)
Figure19.15  (a) Hand foot and mouth disease. Rash on the hand and feet of a 36- year- old man.
KlatschmohnAcker/Wikimedia Commons/CC BY- SA 3.0. (b) Hand foot and mouth disease: Facial skin
and lip lesions in hand, foot and mouth virus disease in an 11- month- old male.  MidgleyDJ/ Wikimedia Commons/CC BY- SA 3.0.
19.2.8  Human Papillomavirus (HPV) Infections
There are many genotypes of HPV implicated in benign and malignant lesions. Low- risk mucosal HPV 6 and 11 cause papillomas and condylomas, while HPV 13 and 32 are associated with focal epithelial hyperplasia (Heck disease). Genotypes 16 and 18 are responsible for some bases of the tongue, tonsillar and oropharyngeal squamous carcinomas. Transmission of the virus occurs by contact either sexually or non- sexually, auto- inoculation or salivary transfer(54).
329
19.2.8.1  Pathogenesis of HPV Infections
Over 150 types of HPV have been identified, although far fewer(14) have been implicated in caus­ing malignant neoplasia. HPV has been divided, for pathogenetic purposes, into ‘low- risk’ and ‘high- risk’ types. The most significant difference between low- and high- risk types is the ability of the high- risk type to integrate their DNA into the host genome. Transmission is person– person through micro- abrasions where the virus gains access to the basal keratinocytes and establishes low- copy infection in these ‘stem’ cells. This protects the virus somewhat from the immune sys­tem’s response. The virus only begins replication when the basal cells begin differentiation and maturation. The virus is shed in high copy as the squamous cells reach the surface of the mucosa or skin.
The proliferative effect of HPV lies primarily in the protein products produced by the viral onco­genes E6 and E7. These proteins interact with the protein products of the tumor suppressor genes p53 and retinoblastoma, respectively, to inhibit their function allowing unchecked cellular division and mutations to occur. HPV infection is cleared or kept in check by the cellular immune system. Defects in this system, such as those seen in AIDS, greatly enhance the oncogenic potential of the virus.
High- risk HPV types are estimated to be the cause of 99% of cervical cancers (there is no evi­dence of significant genetic predisposition for cervical cancer), 90% of anal cancer, 65% vaginal cancers, 50% vulvar cancers and 45– 90% oropharyngeal cancers. Although 14 HPV types are con­sidered high- risk, 16 and 18 are the most important. Low- risk types are site- specific and cause common skin warts, oral warts and laryngeal papillomatosis. Anogenital condyloma is usually
t.me/Dr_Mouayyad_AlbtousH